| 生物活性 | BAY-8400 is an orally active, potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (IC50=81 nM). BAY-8400 can be used for the research ofcancer[1]. | ||||||||||||||||
| IC50& Target | IC50: 81 nM (DNA-PK)[1] | ||||||||||||||||
| 体内研究 (In Vivo) | BAY-8400 (150 mg/kg; p.o.) increases the antitumor efficacy. BAY-8400 shows useful aqueous solubility and oral bioavailability across species[1]. | ||||||||||||||||
| 分子量 | 393.39 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C21H17F2N5O | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
| ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 62.5 mg/mL(158.88 mM;ultrasonic and warming and heat to 60℃) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
| 维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2026 |
